Quick Answer
bioAffinity Technologies, Inc. reported Total Assets of $10.96 million for fiscal year 2025.
bioAffinity Technologies, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $10.96M | +68.3% |
| 2024 | $6.51M | -20.8% |
| 2023 | $8.22M | -32.5% |
| 2022 | $12.18M | +738.2% |
| 2021 | $1.45M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.55M | +76.2% | +143.0% |
| June 30, 2025 | $4.75M | -28.6% | -14.4% |
| March 31, 2025 | $5.55M | -31.1% | -14.8% |
| December 31, 2024 | $6.51M | -20.8% | -0.6% |
| September 30, 2024 | $6.55M | -35.7% | -1.6% |
| June 30, 2024 | $6.66M | -25.0% | -17.3% |
| March 31, 2024 | $8.05M | -23.1% | -2.1% |
| December 31, 2023 | $8.22M | -32.5% | -19.3% |
- bioAffinity Technologies, Inc. showed an increase of +68.3% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, bioAffinity Technologies, Inc.’s total assets has grown by 654.2% (from $1.45 million to $10.96 million).
- The most recent figure is from bioAffinity Technologies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: